[P02BB01, trichlorfon, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Metrifonate.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Isoflurane.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Isoflurane.]
[L04AA27, fingolimod, The metabolism of Fingolimod can be decreased when combined with Isoflurane.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Isoflurane.]
[J01EC01, sulfamethoxazole, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Sulfamethoxazole.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of hypertension can be increased when Sulindac is combined with Isoflurane.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Isoflurane.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sulthiame.]
[M01AX04, apazone, The risk or severity of hypertension can be increased when Isoflurane is combined with Azapropazone.]
[N06DA01, tacrine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Isoflurane.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Isoflurane.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Terbutaline.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Isoflurane.]
[L04AX02, thalidomide, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Isoflurane.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Eribulin.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Isoflurane.]
[L01AC01, thiotepa, The metabolism of Isoflurane can be decreased when combined with Thiotepa.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Isoflurane.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Isoflurane is combined with Thiothixene.]
[B02AB01, aprotinin, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Aprotinin.]
[G04BE06, moxisylyte, The risk or severity of hypertension can be increased when Isoflurane is combined with Moxisylyte.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Isoflurane can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tilidine.]
[S01ED01, timolol, The risk or severity of QTc prolongation can be increased when Timolol is combined with Isoflurane.]
[M02AX02, tolazoline, Isoflurane may decrease the antihypertensive activities of Tolazoline.]
[M02AA21, tolmetin, The risk or severity of hypertension can be increased when Tolmetin is combined with Isoflurane.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of CNS depression can be increased when Isoflurane is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Isoflurane.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Isoflurane.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Isoflurane.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Triazolam.]
[C03AA06, trichlormethiazide, Isoflurane may decrease the antihypertensive activities of Trichlormethiazide.]
[A03AB12, mepenzolate, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[S01EB04, demecarium, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Demecarium.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Trifluoperazine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Trifluperidol.]
[N05AA05, triflupromazine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Trimethadione is combined with Isoflurane.]
[C02BA01, trimethaphan, Isoflurane may decrease the antihypertensive activities of Trimethaphan.]
[N06AA06, trimipramine, The risk or severity of adverse effects can be increased when Trimipramine is combined with Isoflurane.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Isoflurane.]
[A03BB01, butylscopolamine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vilazodone.]
[S01FA06, tropicamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tropicamide.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Isoflurane.]
[C09CA09, azilsartan medoxomil, Isoflurane may decrease the antihypertensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tubocurarine.]
[S01AA05, tyrothricin, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Tyrothricin.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Vandetanib.]
[J05AG05, rilpivirine, The metabolism of Isoflurane can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ezogabine.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Indacaterol.]
[C08DA01, verapamil, The risk or severity of myocardial depression can be increased when Verapamil is combined with Isoflurane.]
[N06AX09, viloxazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Viloxazine.]
[C04AX07, vincamine, Isoflurane may decrease the antihypertensive activities of Vincamine.]
[N01AX15, xenon, The therapeutic efficacy of Xenon can be increased when used in combination with Isoflurane.]
[C03BA10, xipamide, Isoflurane may decrease the antihypertensive activities of Xipamide.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Zuclopenthixol.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Levetiracetam.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Vemurafenib.]
[L01ED01, crizotinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Crizotinib.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Isoflurane.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ziprasidone.]
[N02BA01, aspirin, The risk or severity of hypertension can be increased when Isoflurane is combined with Acetylsalicylic acid.]
[G04BD07, tolterodine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, Isoflurane may decrease the antihypertensive activities of Atenolol.]
[J02AC03, voriconazole, The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Isoflurane.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Isoflurane is combined with Atracurium.]
[S01FA01, atropine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[G04BE10, avanafil, The risk or severity of hypotension can be increased when Avanafil is combined with Isoflurane.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[A08AA11, lorcaserin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Lorcaserin.]
[G04BD12, mirabegron, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Mirabegron.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Isoflurane.]
[C01CA18, octopamine, The risk or severity of hypertension can be increased when Isoflurane is combined with Octopamine.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Isoflurane.]
[J05AE04, nelfinavir, The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Isoflurane.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Isoflurane is combined with Rasagiline.]
[C08CA13, lercanidipine, Isoflurane may decrease the antihypertensive activities of Lercanidipine.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Isoflurane is combined with Mosapride.]
[N06DA02, donepezil, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Isoflurane.]
[R06AC06, thonzylamine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AB02, chloroform, The therapeutic efficacy of Chloroform can be increased when used in combination with Isoflurane.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Isoflurane is combined with Diethyl ether.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Pasireotide.]
[G04BE03, sildenafil, The metabolism of Isoflurane can be decreased when combined with Sildenafil.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Bencyclane.]
[C03AA01, bendroflumethiazide, Isoflurane may decrease the antihypertensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Isoflurane.]
[N02BA10, benorilate, The risk or severity of hypertension can be increased when Isoflurane is combined with Benorilate.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Benperidol.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Canagliflozin.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Moxifloxacin.]
[A06AX06, tegaserod, The therapeutic efficacy of Tegaserod can be decreased when used in combination with Isoflurane.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Benzocaine.]
[M01AH01, celecoxib, The risk or severity of hypertension can be increased when Celecoxib is combined with Isoflurane.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Isoflurane is combined with Naratriptan.]
[N04AC01, benztropine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Isoflurane can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of hypertension can be increased when Isoflurane is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of adverse effects can be increased when Isoflurane is combined with Levomilnacipran.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Bepridil.]
[C02KX05, riociguat, Isoflurane may decrease the antihypertensive activities of Riociguat.]
[C02KX04, macitentan, Isoflurane may decrease the antihypertensive activities of Macitentan.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Eslicarbazepine.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypertension can be increased when Isoflurane is combined with Droxidopa.]
[C07AB04, acebutolol, Isoflurane may decrease the antihypertensive activities of Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tasimelteon.]
[L04AA32, apremilast, The metabolism of Isoflurane can be increased when combined with Apremilast.]
[A16AA06, betaine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Betaine.]
[S03BA03, betamethasone, The metabolism of Isoflurane can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, Isoflurane may decrease the antihypertensive activities of Betaxolol.]
[V03AB34, fomepizole, The metabolism of Isoflurane can be decreased when combined with Fomepizole.]
[C02CC01, bethanidine, Isoflurane may decrease the antihypertensive activities of Bethanidine.]
[L04AC11, siltuximab, The metabolism of Isoflurane can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ceritinib.]
[A03BA03, hyoscyamine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Alfaxalone.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Olodaterol.]
[D11AA01, glycopyrronium, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Eliglustat.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Acepromazine.]
[V04CX03, methacholine, Isoflurane may decrease effectiveness of Methacholine as a diagnostic agent.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Isoflurane.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Naloxegol.]
[N04AA02, biperiden, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Isoflurane.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Isoflurane.]
[N06AX11, mirtazapine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Isoflurane can be increased when combined with Secukinumab.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Panobinostat.]
[N02BE01, acetaminophen, Isoflurane may increase the hepatotoxic activities of Acetaminophen.]
[A03AA09, difemerine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ivabradine.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Isoflurane.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Isoflurane is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Isoflurane is combined with Brexpiprazole.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Flibanserin.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Isoflurane.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Cariprazine.]
[M02AA25, aceclofenac, The risk or severity of hypertension can be increased when Isoflurane is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hypertension can be increased when Isoflurane is combined with Acemetacin.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Acetophenazine.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Isoflurane.]
[J02AC05, isavuconazole, The metabolism of Isoflurane can be increased when combined with Isavuconazole.]
[B01AC27, selexipag, Isoflurane may decrease the antihypertensive activities of Selexipag.]
[G04CA01, alfuzosin, The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Isoflurane.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Isoflurane is combined with Aprobarbital.]
[M01AE16, alminoprofen, The risk or severity of hypertension can be increased when Isoflurane is combined with Alminoprofen.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Brivaracetam.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Isoflurane.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Amineptine.]
[C08CA01, amlodipine, Isoflurane may decrease the antihypertensive activities of Amlodipine.]
[N01AH05, anileridine, The therapeutic efficacy of Anileridine can be increased when used in combination with Isoflurane.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Aniracetam.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Isoflurane.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Bupranolol.]
[N07BC01, buprenorphine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Buserelin.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Isoflurane.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Rivastigmine.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Artemether.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Butorphanol.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Isoflurane.]
[S01GX07, azelastine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Azithromycin.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Isoflurane.]
[L01EF02, ribociclib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of hypertension can be increased when Isoflurane is combined with Balsalazide.]
[R03CC12, bambuterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Bambuterol.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The therapeutic efficacy of Isoflurane can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Beclamide.]
[C09AA07, benazepril, Isoflurane may decrease the antihypertensive activities of Benazepril.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxybuprocaine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Isoflurane is combined with Linezolid.]
[L04AB02, infliximab, The metabolism of Isoflurane can be increased when combined with Infliximab.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Safinamide.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Delafloxacin.]
[D01AC10, bifonazole, The metabolism of Isoflurane can be decreased when combined with Bifonazole.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Isoflurane.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Vorinostat.]
[C07AB07, bisoprolol, Isoflurane may decrease the antihypertensive activities of Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Bitolterol.]
[J05AG03, efavirenz, The risk or severity of adverse effects can be increased when Efavirenz is combined with Isoflurane.]
[C07AA17, bopindolol, Isoflurane may increase the cardiodepressant activities of Bopindolol.]
[N04AA11, bornaprine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nesiritide.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Brotizolam.]
[C04AX20, buflomedil, The risk or severity of hypertension can be increased when Isoflurane is combined with Buflomedil.]
[M01AB07, bumadizone, The risk or severity of hypertension can be increased when Isoflurane is combined with Bumadizone.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Isoflurane is combined with Butobarbital.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Isoflurane is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Acetyldigoxin.]
[N01BX04, capsaicin, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Capsaicin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vinylbital.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Acrivastine.]
[C09AA01, captopril, Isoflurane may decrease the antihypertensive activities of Captopril.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Macimorelin.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Isoflurane.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Isoflurane.]
[A03AA03, camylofine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Isoflurane.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Isoflurane.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Isoflurane.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Isoflurane.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Encorafenib.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Celiprolol.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ivosidenib.]
[N03AX17, stiripentol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Stiripentol.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Isoflurane.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Isoflurane is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The risk or severity of hypertension can be increased when Isoflurane is combined with Lornoxicam.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Inotersen.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Isoflurane.]
[R03BB08, revefenacin, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L04AA39, emapalumab, The metabolism of Isoflurane can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Gilteritinib.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Isoflurane is combined with Amifampridine.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Isoflurane.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Cibenzoline.]
[C09AA08, cilazapril, Isoflurane may decrease the antihypertensive activities of Cilazapril.]
[B01AC23, cilostazol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Cilostazol.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Isoflurane is combined with Cinitapride.]
[P02BX04, triclabendazole, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Isoflurane.]
[L04AA42, siponimod, The risk or severity of hypertension can be increased when Isoflurane is combined with Siponimod.]
[J01FA09, clarithromycin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Isoflurane.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Brexanolone.]
[N05BA09, clobazam, The risk or severity of adverse effects can be increased when Clobazam is combined with Isoflurane.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Isoflurane.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Cloxazolam.]
[C09CA06, candesartan, Isoflurane may decrease the antihypertensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Isoflurane can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The metabolism of Isoflurane can be increased when combined with Alpelisib.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Cyamemazine.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Cicletanine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Isoflurane.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Entrectinib.]
[N07XX11, pitolisant, Isoflurane may increase the QTc-prolonging activities of Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Isoflurane.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Isoflurane.]
[C03AA09, cyclothiazide, Isoflurane may decrease the antihypertensive activities of Cyclothiazide.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Yohimbine.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Isoflurane.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Isoflurane.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Isoflurane.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Isoflurane.]
[N03AX25, cenobamate, The serum concentration of Isoflurane can be decreased when it is combined with Cenobamate.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Isoflurane.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Dexchlorpheniramine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dezocine.]
[N05CM21, lemborexant, The serum concentration of Isoflurane can be decreased when it is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Isoflurane can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Osilodrostat can be decreased when combined with Isoflurane.]
[J05AE05, amprenavir, The metabolism of Isoflurane can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Isoflurane is combined with Frovatriptan.]
[G04CB02, dutasteride, The risk or severity of hypertension can be increased when Isoflurane is combined with Dutasteride.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Isoflurane.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Isoflurane.]
[M01AH02, rofecoxib, The risk or severity of hypertension can be increased when Rofecoxib is combined with Isoflurane.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Clevidipine.]
[C01BD07, dronedarone, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Valpromide.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Chlorcyclizine.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Isoflurane.]
[C02AA06, methoserpidine, Isoflurane may decrease the antihypertensive activities of Methoserpidine.]
[A03AA08, dihexyverine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Opicapone.]
[C01CA14, dopexamine, The risk or severity of hypertension can be increased when Isoflurane is combined with Dopexamine.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Isoflurane.]
[G04BD09, trospium, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The risk or severity of hypertension can be increased when Isoflurane is combined with Droxicam.]
[L01EX22, selpercatinib, The risk or severity of hypertension can be increased when Isoflurane is combined with Selpercatinib.]
[M02AA27, dexketoprofen, The risk or severity of hypertension can be increased when Isoflurane is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Isoflurane is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Dyclonine is combined with Isoflurane.]
[C08CA17, levamlodipine, Isoflurane may decrease the antihypertensive activities of Levamlodipine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ebastine.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Fostemsavir.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Remimazolam.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Isoflurane is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Chloroquine.]
[C03AA04, chlorothiazide, Isoflurane may decrease the antihypertensive activities of Chlorothiazide.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.]
[N05AF03, chlorprothixene, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, Isoflurane may decrease the antihypertensive activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Isoflurane.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Etifoxine.]
[N02BA07, ethenzamide, The risk or severity of hypertension can be increased when Isoflurane is combined with Ethenzamide.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ethyl loflazepate.]
[M01AB08, etodolac, The risk or severity of hypertension can be increased when Etodolac is combined with Isoflurane.]
[M02AA06, etofenamate, The risk or severity of hypertension can be increased when Isoflurane is combined with Etofenamate.]
[B06AC06, berotralstat, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Berotralstat.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Relugolix.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Isoflurane is combined with Naxitamab.]
[P03AX07, abametapir, The serum concentration of Isoflurane can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vericiguat.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of hypertension can be increased when Isoflurane is combined with Fenbufen.]
[C01CA19, fenoldopam, Isoflurane may decrease the antihypertensive activities of Fenoldopam.]
[N06BA08, fenozolone, The risk or severity of hypertension can be increased when Isoflurane is combined with Fenozolone.]
[G04CB01, finasteride, The risk or severity of hypertension can be increased when Isoflurane is combined with Finasteride.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Flumequine.]
[R03CC15, formoterol, Isoflurane may increase the arrhythmogenic activities of Formoterol.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Isoflurane.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Isoflurane is combined with Trichloroethylene.]
[H04AA02, dasiglucagon, Isoflurane may decrease the antihypertensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The metabolism of Isoflurane can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Isoflurane can be decreased when combined with Cinnarizine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The metabolism of Isoflurane can be decreased when combined with Cisplatin.]
[N06AB04, citalopram, The risk or severity of adverse effects can be increased when Isoflurane is combined with Citalopram.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Isoflurane is combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Mobocertinib.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Clemastine.]
[R03CC13, clenbuterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Clenbuterol.]
[N06AX25, St. John's wort extract, The risk or severity of adverse effects can be increased when Isoflurane is combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Isoflurane.]
[J04BA01, clofazimine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Isoflurane can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Isoflurane can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Pacritinib.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Clomipramine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Isoflurane.]
[C01EB24, mavacamten, The metabolism of Isoflurane can be increased when combined with Mavacamten.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Isoflurane is combined with Granisetron.]
[N05AH02, clozapine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Clozapine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Halazepam.]
[S02DA02, cocaine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, Isoflurane may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Isoflurane can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of hypertension can be increased when Isoflurane is combined with Proquazone.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Codeine.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Isoflurane is combined with Hexafluronium.]
[A03AB10, hexocyclium, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[S01FA05, homatropine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Homatropine.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ifenprodil.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hypertension can be increased when Isoflurane is combined with Imidazole salicylate.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Telithromycin.]
[B01AC10, indobufen, The risk or severity of hypertension can be increased when Isoflurane is combined with Indobufen.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Desloratadine.]
[M01AH03, valdecoxib, The risk or severity of hypertension can be increased when Valdecoxib is combined with Isoflurane.]
[H01AX01, pegvisomant, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Pegvisomant.]
[A03AX10, isometheptene, The risk or severity of hypertension can be increased when Isoflurane is combined with Isometheptene.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Isoflurane is combined with Almotriptan.]
[M01AH04, parecoxib, The risk or severity of hypertension can be increased when Isoflurane is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Isoflurane can be decreased when combined with Itraconazole.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Emedastine.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ketazolam.]
[M01AA06, kebuzone, The risk or severity of hypertension can be increased when Isoflurane is combined with Kebuzone.]
[L01EA01, imatinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Imatinib.]
[J02AC04, posaconazole, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Posaconazole.]
[C08CA09, lacidipine, Isoflurane may increase the hypotensive activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Isoflurane.]
[N03AX09, lamotrigine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Levocabastine.]
[N07BC04, lofexidine, The therapeutic efficacy of Isoflurane can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of hypertension can be increased when Isoflurane is combined with Lonazolac.]
[R06AX13, loratadine, Isoflurane may increase the anticholinergic activities of Loratadine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Lormetazepam.]
[M02AA31, loxoprofen, The risk or severity of hypertension can be increased when Isoflurane is combined with Loxoprofen.]
[C09AA03, lisinopril, Isoflurane may decrease the antihypertensive activities of Lisinopril.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Isoflurane.]
[C08CA11, manidipine, Isoflurane may decrease the antihypertensive activities of Manidipine.]
[A03AA04, mebeverine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Medifoxamine.]
[A08AA09, mefenorex, The risk or severity of hypertension can be increased when Isoflurane is combined with Mefenorex.]
[C07AA14, mepindolol, Isoflurane may increase the cardiodepressant activities of Mepindolol.]
[R06AD07, mequitazine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Mequitazine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Adenosine.]
[N04AA03, methixene, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R03CB02, methoxyphenamine, The risk or severity of hypertension can be increased when Isoflurane is combined with Methoxyphenamine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Isoflurane is combined with Cyclobarbital.]
[C03DA04, eplerenone, Isoflurane may decrease the antihypertensive activities of Eplerenone.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Isoflurane is combined with Melperone.]
[C03AA07, cyclopenthiazide, Isoflurane may decrease the antihypertensive activities of Cyclopenthiazide.]
[S01FA04, cyclopentolate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Cyclopentolate.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Isoflurane.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Minaprine.]
[S01XA18, cyclosporine, The risk or severity of hypertension can be increased when Cyclosporine is combined with Isoflurane.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Isoflurane can be increased when combined with Armodafinil.]
[R06AX02, cyproheptadine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Isoflurane.]
[M02AA02, mofebutazone, The risk or severity of hypertension can be increased when Isoflurane is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hypertension can be increased when Isoflurane is combined with Morniflumate.]
[C03XA02, conivaptan, The risk or severity of adverse effects can be increased when Isoflurane is combined with Conivaptan.]
[C02AC05, moxonidine, Isoflurane may decrease the antihypertensive activities of Moxonidine.]
[G04BE09, vardenafil, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Vardenafil.]
[M01AH05, etoricoxib, The risk or severity of hypertension can be increased when Isoflurane is combined with Etoricoxib.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dantrolene.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Deanol.]
[C02CC04, debrisoquin, Isoflurane may decrease the antihypertensive activities of Debrisoquine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[M01AX01, nabumetone, The risk or severity of hypertension can be increased when Nabumetone is combined with Isoflurane.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nordazepam.]
[C07AB12, nebivolol, Isoflurane may decrease the antihypertensive activities of Nebivolol.]
[N06AX06, nefazodone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Niaprazine.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Isoflurane.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tiagabine.]
[C01CA23, theodrenaline, The risk or severity of hypertension can be increased when Isoflurane is combined with Theodrenaline.]
[M03AC11, cisatracurium, Isoflurane may increase the neuromuscular blocking activities of Cisatracurium.]
[C01CA05, norfenefrine, The risk or severity of hypertension can be increased when Isoflurane is combined with Norfenefrine.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of adverse effects can be increased when Isoflurane is combined with Escitalopram.]
[G04BD08, solifenacin, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hypertension can be increased when Isoflurane is combined with Olsalazine.]
[N06AA01, desipramine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Desipramine.]
[H01BA02, desmopressin, The risk or severity of hypertension can be increased when Desmopressin is combined with Isoflurane.]
[C09XA02, aliskiren, Isoflurane may decrease the antihypertensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Oxaliplatin.]
[M01AE12, oxaprozin, The risk or severity of hypertension can be increased when Isoflurane is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Isoflurane can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxiracetam.]
[N04AA08, dexetimide, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Isoflurane can be decreased when combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Isoflurane can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, The risk or severity of hypertension can be increased when Amphetamine is combined with Isoflurane.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Isoflurane.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Paramethadione is combined with Isoflurane.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Isoflurane can be decreased when combined with Clopidogrel.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Phenacemide.]
[V03AH01, diazoxide, Isoflurane may decrease the antihypertensive activities of Diazoxide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Cinchocaine is combined with Isoflurane.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Diclofenamide.]
[S01BC03, diclofenac, The metabolism of Isoflurane can be decreased when combined with Diclofenac.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Isoflurane.]
[A03AA07, dicyclomine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[C02DG01, pinacidil, Isoflurane may decrease the antihypertensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Pinaverium.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pipamperone.]
[A03AB14, pipenzolate, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Erlotinib.]
[R03CC07, pirbuterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Pirbuterol.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Diethylcarbamazine.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Isoflurane is combined with Diethylpropion.]
[L02AA01, diethylstilbestrol, The metabolism of Isoflurane can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The risk or severity of QTc prolongation can be increased when Isradipine is combined with Isoflurane.]
[A03AB11, poldine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The risk or severity of hypertension can be increased when Isoflurane is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Digitoxin.]
[C01AA05, digoxin, The risk or severity of QTc prolongation can be increased when Digoxin is combined with Isoflurane.]
[C02DB01, dihydralazine, Isoflurane may decrease the antihypertensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, The risk or severity of hypertension can be increased when Isoflurane is combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Isoflurane.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Hydromorphone.]
[J05AE08, atazanavir, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Isoflurane.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pramocaine.]
[C08DB01, diltiazem, Isoflurane may decrease the antihypertensive activities of Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pridinol.]
[R06AB03, dimethindene, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Procaterol.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Progabide.]
[N02BB04, propyphenazone, The risk or severity of hypertension can be increased when Isoflurane is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hypertension can be increased when Isoflurane is combined with Proglumetacin.]
[C05CA03, diosmin, The metabolism of Isoflurane can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Quazepam.]
[C09AA06, quinapril, Isoflurane may decrease the antihypertensive activities of Quinapril.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dipyridamole.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may increase the hypertensive activities of Isoflurane.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Quinupramine.]
[A03FA02, cisapride, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Cisapride.]
[C09AA05, ramipril, Isoflurane may decrease the antihypertensive activities of Ramipril.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Isoflurane.]
[R03CC14, reproterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Reproterol.]
[C01BA03, disopyramide, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[N07AA03, distigmine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Distigmine.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Isoflurane can be decreased when combined with Rifamycin.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Riluzole is combined with Isoflurane.]
[N05AX08, risperidone, Isoflurane may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Isoflurane.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Sunitinib.]
[L01XG01, bortezomib, The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Isoflurane.]
[G04BE08, tadalafil, Isoflurane may decrease the antihypertensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of hypertension can be increased when Ketorolac is combined with Isoflurane.]
[C02KX02, ambrisentan, Isoflurane may decrease the antihypertensive activities of Ambrisentan.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ranolazine.]
[N02BA06, salsalate, The risk or severity of hypertension can be increased when Isoflurane is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of hypertension can be increased when Isoflurane is combined with Dobutamine.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Domperidone.]
[C01CA04, dopamine, Isoflurane may increase the arrhythmogenic activities of Dopamine.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Isoflurane.]
[R07AB01, doxapram, The risk or severity of hypertension can be increased when Doxapram is combined with Isoflurane.]
[N06AA12, doxepin, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Doxepin.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Isoflurane.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[N06AB06, sertraline, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[A08AA10, sibutramine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Isoflurane can be increased when combined with Simvastatin.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Isoflurane.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Isoflurane.]
[C09AA11, spirapril, Isoflurane may decrease the antihypertensive activities of Spirapril.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Sumatriptan is combined with Isoflurane.]
[V04CX07, edrophonium, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Edrophonium.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Talinolol.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Temafloxacin.]
[M01AC02, tenoxicam, The risk or severity of hypertension can be increased when Tenoxicam is combined with Isoflurane.]
[G04CA03, terazosin, Isoflurane may decrease the antihypertensive activities of Terazosin.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Terodiline.]
[C07AA16, tertatolol, Isoflurane may increase the cardiodepressant activities of Tertatolol.]
[S01GA02, tetrahydrozoline, The risk or severity of hypertension can be increased when Isoflurane is combined with Tetryzoline.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Isoflurane is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Thiopropazate.]
[G04BD01, emepronium, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tianeptine.]
[C09AA02, enalapril, Isoflurane may decrease the antihypertensive activities of Enalapril.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Tofisopam.]
[M01AG02, tolfenamic acid, The risk or severity of hypertension can be increased when Isoflurane is combined with Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Toloxatone.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Isoflurane.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Isoflurane.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Toremifene.]
[C03CA04, torsemide, Isoflurane may decrease the antihypertensive activities of Torasemide.]
[R01AA09, tramazoline, The risk or severity of hypertension can be increased when Isoflurane is combined with Tramazoline.]
[C09AA10, trandolapril, Isoflurane may decrease the antihypertensive activities of Trandolapril.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Isoflurane is combined with Triclofos.]
[A03AB08, tridihexethyl, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Isoflurane.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Triptorelin.]
[N04AA12, tropatepine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[R03CC11, tulobuterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Tulobuterol.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Isoflurane.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Isoflurane is combined with Urapidil.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Isoflurane.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Isoflurane is combined with Veralipride.]
[S01FB02, ephedrine, Ephedrine may increase the arrhythmogenic activities of Isoflurane.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Epinastine is combined with Isoflurane.]
[N06AX16, venlafaxine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Isoflurane.]
[C01CX07, xamoterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Xamoterol.]
[S01GA03, xylometazoline, The risk or severity of hypertension can be increased when Isoflurane is combined with Xylometazoline.]
[C08CA12, mepirodipine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Barnidipine.]
[S01EA01, epinephrine, Isoflurane may increase the arrhythmogenic activities of Epinephrine.]
[C09AA15, zofenopril, Isoflurane may decrease the antihypertensive activities of Zofenopril.]
[N05CF02, zolpidem, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, The risk or severity of hypertension can be increased when Isoflurane is combined with Zomepirac.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Zonisamide.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Guanfacine.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Isoflurane is combined with Iloprost.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Moricizine is combined with Isoflurane.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The risk or severity of adverse effects can be increased when Ergotamine is combined with Isoflurane.]
[N03AG01, valproic acid, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Valproic acid.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Estazolam.]
[J04AK02, ethambutol, The metabolism of Isoflurane can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The metabolism of Isoflurane can be increased when combined with Fluvastatin.]
[C01CA15, gepefrine, The risk or severity of hypertension can be increased when Isoflurane is combined with Gepefrine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Isoflurane.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Amifostine.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ibutilide.]
[N04AA05, profenamine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Ethosuximide is combined with Isoflurane.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ethotoin.]
[M01AC06, meloxicam, The risk or severity of hypertension can be increased when Isoflurane is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ethylmorphine.]
[C01CA01, etilefrine, The risk or severity of hypertension can be increased when Isoflurane is combined with Etilefrine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Isoflurane.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sertindole.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ajmaline.]
[L04AD02, tacrolimus, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Tacrolimus.]
[A02BA04, nizatidine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Nizatidine.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Fleroxacin.]
[R06AX11, astemizole, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Astemizole.]
[R06AX12, terfenadine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Isoflurane.]
[N06AB08, fluvoxamine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Fluvoxamine.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Encainide.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Leuprolide.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Famotidine.]
[C08CA02, felodipine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Fendiline.]
[N03AX26, fenfluramine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Isoflurane.]
[M01AE04, fenoprofen, The risk or severity of hypertension can be increased when Fenoprofen is combined with Isoflurane.]
[R03CC04, fenoterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Fenoterol.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Isoflurane is combined with Fentanyl.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Salbutamol.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Isoflurane.]
[G04BD02, flavoxate, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Flecainide.]
[N02BG04, floctafenine, The risk or severity of hypertension can be increased when Isoflurane is combined with Floctafenine.]
[J02AC01, fluconazole, The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Isoflurane.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Isoflurane is combined with Melitracen.]
[V03AZ01, ethanol, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC02, fluorouracil, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Fluorouracil.]
[N06AB03, fluoxetine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Isoflurane.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Flurazepam is combined with Isoflurane.]
[S01BC04, flurbiprofen, The risk or severity of hypertension can be increased when Flurbiprofen is combined with Isoflurane.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Isoflurane is combined with Fluspirilene.]
[N06BX17, adrafinil, The risk or severity of hypertension can be increased when Isoflurane is combined with Adrafinil.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Isoflurane is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Furazolidone.]
[C03CA01, furosemide, Isoflurane may decrease the antihypertensive activities of Furosemide.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Isoflurane is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Isoflurane is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Isoflurane.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Gallamine.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Gallopamil.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Isoflurane.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Bifemelane.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Degarelix.]
[L01EA02, dasatinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Dasatinib.]
[N04BC06, cabergoline, The risk or severity of adverse effects can be increased when Cabergoline is combined with Isoflurane.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Isoflurane is combined with Alfentanil.]
[L01EH01, lapatinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Lapatinib.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Isoflurane.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Glutethimide.]
[A06AX01, glycerin, The metabolism of Isoflurane can be increased when combined with Glycerin.]
[C05AE01, nitroglycerin, Isoflurane may decrease the antihypertensive activities of Nitroglycerin.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Dofetilide.]
[C02CA04, doxazosin, Isoflurane may decrease the antihypertensive activities of Doxazosin.]
[L01EX02, sorafenib, The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Isoflurane.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Isoflurane.]
[C09AA09, fosinopril, Isoflurane may decrease the antihypertensive activities of Fosinopril.]
[S01EX01, guanethidine, Isoflurane may decrease the antihypertensive activities of Guanethidine.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Goserelin.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Haloperidol.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Halothane.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Histrelin.]
[N05AH04, quetiapine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Isoflurane is combined with Iprazochrome.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Isoflurane.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Isoflurane is combined with Allobarbital.]
[C09CA01, losartan, The risk or severity of QTc prolongation can be increased when Losartan is combined with Isoflurane.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Isoflurane.]
[A07EC02, mesalamine, The risk or severity of hypertension can be increased when Mesalazine is combined with Isoflurane.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Isoflurane.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Isoflurane.]
[R03CC05, hexoprenaline, The risk or severity of hypertension can be increased when Isoflurane is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Isoflurane can be increased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Nilvadipine can be decreased when combined with Isoflurane.]
[M02AA26, nimesulide, The risk or severity of hypertension can be increased when Isoflurane is combined with Nimesulide.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Oxatomide.]
[C09AA04, perindopril, Isoflurane may decrease the antihypertensive activities of Perindopril.]
[C02DB02, hydralazine, Isoflurane may decrease the antihypertensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Hydrochlorothiazide.]
[R05DA03, hydrocodone, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Isoflurane can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, Isoflurane may decrease the antihypertensive activities of Hydroflumethiazide.]
[G04BD06, propiverine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Isoflurane is combined with Prothipendyl.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Isoflurane can be increased when combined with Rifabutin.]
[C02AC06, rilmenidine, Isoflurane may decrease the antihypertensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The risk or severity of hypertension can be increased when Isoflurane is combined with Ibuprofen.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Isoflurane.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Isoflurane.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sufentanil.]
[N06AA02, imipramine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Imipramine.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Isoflurane is combined with Paclitaxel.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Terlipressin.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Isoflurane.]
[C03BA11, indapamide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Indapamide.]
[S01BC01, indomethacin, The risk or severity of hypertension can be increased when Indomethacin is combined with Isoflurane.]
[C02CA02, indoramin, Isoflurane may decrease the antihypertensive activities of Indoramin.]
[N06AX17, milnacipran, The risk or severity of adverse effects can be increased when Isoflurane is combined with Milnacipran.]
[A03AA30, piperidolate, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Alprazolam is combined with Isoflurane.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ramelteon.]
[R06AE01, buclizine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Isoflurane can be increased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Anagrelide.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Alprenolol.]
[C03BA02, quinethazone, The serum concentration of Quinethazone can be increased when it is combined with Isoflurane.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Isoflurane is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Isoflurane is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Isoflurane is combined with Isocarboxazid.]
[R03CC06, isoetharine, The risk or severity of hypertension can be increased when Isoetharine is combined with Isoflurane.]
[C09AA16, imidapril, Isoflurane may decrease the antihypertensive activities of Imidapril.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Pipemidic acid.]
[N07XX04, sodium oxybate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Sodium oxybate.]
[M01AG01, mefenamic acid, The risk or severity of hypertension can be increased when Isoflurane is combined with Mefenamic acid.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Isoflurophate.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Isoflurane.]
[J04AC01, isoniazid, The metabolism of Isoflurane can be decreased when combined with Isoniazid.]
[R03CB01, isoproterenol, Isoflurane may increase the arrhythmogenic activities of Isoprenaline.]
[C05AE02, isosorbide dinitrate, The metabolism of Isoflurane can be decreased when combined with Isosorbide dinitrate.]
[C04AA01, isoxsuprine, The risk or severity of hypertension can be increased when Isoflurane is combined with Isoxsuprine.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Isoflurane.]
[L04AC07, tocilizumab, The metabolism of Isoflurane can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Isoflurane.]
[J02AB02, ketoconazole, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ketoconazole.]
[N05AH03, olanzapine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of hypertension can be increased when Isoflurane is combined with Ketoprofen.]
[L04AA24, abatacept, The metabolism of Isoflurane can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Mizolastine.]
[C01CA22, arbutamine, The risk or severity of hypertension can be increased when Isoflurane is combined with Arbutamine.]
[N04BC09, rotigotine, Isoflurane may increase the sedative activities of Rotigotine.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Nalidixic acid.]
[C07AG01, labetalol, Isoflurane may decrease the antihypertensive activities of Labetalol.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Amantadine.]
[C02AA05, deserpidine, Isoflurane may decrease the antihypertensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Isoflurane.]
[N07AA30, ambenonium, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Ambenonium.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Isoflurane.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Lacosamide.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Isoflurane is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Isoflurane.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Lidoflazine.]
[N06BA13, armodafinil, The metabolism of Isoflurane can be increased when combined with Armodafinil.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Isoflurane.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Lisuride is combined with Isoflurane.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Lofepramine.]
[A07DA03, loperamide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Loperamide.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Isoflurane.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Isoflurane.]
[G04BX01, magnesium hydroxide, The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Isoflurane.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Isoflurane.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Isoflurane can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Isoflurane.]
[N06AA21, maprotiline, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Isoflurane.]
[C02BB01, mecamylamine, Isoflurane may decrease the antihypertensive activities of Mecamylamine.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Mechlorethamine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Meclizine is combined with Isoflurane.]
[M02AA18, meclofenamic acid, The risk or severity of hypertension can be increased when Isoflurane is combined with Meclofenamic acid.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Medazepam.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Isoflurane.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Isoflurane.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Melatonin.]
[N06DX01, memantine, The metabolism of Isoflurane can be decreased when combined with Memantine.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Meperidine.]
[C01CA11, mephentermine, The risk or severity of hypertension can be increased when Isoflurane is combined with Mephentermine.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Mephenytoin is combined with Isoflurane.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Isoflurane.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Isoflurane.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Meptazinol.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Paliperidone.]
[C01CA09, metaraminol, The risk or severity of hypertension can be increased when Metaraminol is combined with Isoflurane.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Isoflurane.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Metamfetamine.]
[A03AB07, methantheline, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Isoflurane is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Isoflurane.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Isoflurane.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Isoflurane is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Isoflurane can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Isoflurane.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Isoflurane.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Ziconotide.]
[N05AA02, methotrimeprazine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[C01CA10, methoxamine, The risk or severity of hypertension can be increased when Methoxamine is combined with Isoflurane.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The serum concentration of Methyclothiazide can be increased when it is combined with Isoflurane.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Isoflurane.]
[C02AB01, methyldopa, Isoflurane may decrease the antihypertensive activities of Methyldopa.]
[V04CG05, methylene blue, The risk or severity of adverse effects can be increased when Isoflurane is combined with Methylene blue.]
[G02AB01, methylergonovine, The risk or severity of hypertension can be increased when Methylergometrine is combined with Isoflurane.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Isoflurane.]
[N06BA04, methylphenidate, Methylphenidate may increase the hypertensive activities of Isoflurane.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Isoflurane.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Isoflurane.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Isoflurane is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Isoflurane.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Isoflurane.]
[C03BA08, metolazone, Isoflurane may decrease the antihypertensive activities of Metolazone.]
[C07AB02, metoprolol, Isoflurane may decrease the antihypertensive activities of Metoprolol.]
[P01AB01, metronidazole, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Metronidazole.]
[C01BB02, mexiletine, The metabolism of Isoflurane can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Isoflurane is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Isoflurane can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of hypertension can be increased when Isoflurane is combined with Aminophenazone.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Midazolam is combined with Isoflurane.]
[C01CA17, midodrine, The risk or severity of hypertension can be increased when Midodrine is combined with Isoflurane.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Mifepristone.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Isoflurane.]
[C09CA03, valsartan, Isoflurane may decrease the antihypertensive activities of Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[D11AX01, minoxidil, Isoflurane may decrease the antihypertensive activities of Minoxidil.]
[L01DB07, mitoxantrone, The metabolism of Isoflurane can be increased when combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The risk or severity of hypertension can be increased when Isoflurane is combined with Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Molindone.]
[L03AC01, aldesleukin, The metabolism of Isoflurane can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, Amiodarone may increase the cardiodepressant activities of Isoflurane.]
[N06AA09, amitriptyline, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Morphine.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Isoflurane.]
[L04AB05, certolizumab pegol, The metabolism of Isoflurane can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Pazopanib.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vecuronium.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Isoflurane.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Isoflurane.]
[G03XC01, raloxifene, The metabolism of Isoflurane can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.]
[N03AB05, fosphenytoin, The metabolism of Isoflurane can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Isoflurane may decrease the antihypertensive activities of Nadolol.]
[N04BC04, ropinirole, Isoflurane may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Isoflurane is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nalbuphine.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Isoflurane can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of hypertension can be increased when Isoflurane is combined with Naphazoline.]
[N06BA01, amphetamine, The risk or severity of hypertension can be increased when Amphetamine is combined with Isoflurane.]
[M02AA12, naproxen, The risk or severity of hypertension can be increased when Isoflurane is combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Isoflurane can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Isoflurane is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Isoflurane.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Isoflurane is combined with Remifentanil.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Levosimendan.]
[S01EB06, neostigmine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Neostigmine.]
[N05AX14, iloperidone, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isoflurane.]
[N06AX23, desvenlafaxine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Desvenlafaxine.]
[C09CA07, telmisartan, Isoflurane may decrease the antihypertensive activities of Telmisartan.]
[C10AD02, niacin, The metabolism of Isoflurane can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nialamide.]
[C08CA04, nicardipine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.]
[C04AE02, nicergoline, The risk or severity of hypertension can be increased when Nicergoline is combined with Isoflurane.]
[N07BA01, nicotine, The metabolism of Isoflurane can be increased when combined with Nicotine.]
[C08CA05, nifedipine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hypertension can be increased when Isoflurane is combined with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Isoflurane is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Isoflurane may decrease the antihypertensive activities of Nimodipine.]
[C08CA07, nisoldipine, Isoflurane may decrease the antihypertensive activities of Nisoldipine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nitrazepam.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Isoflurane.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Isoflurane is combined with Zaleplon.]
[N04BC05, pramipexole, Isoflurane may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Isoflurane may decrease the antihypertensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Nomifensine.]
[C01CA03, norepinephrine, Isoflurane may increase the arrhythmogenic activities of Norepinephrine.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Norfloxacin.]
[C02KX01, bosentan, Isoflurane may decrease the antihypertensive activities of Bosentan.]
[N06AA10, nortriptyline, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.]
[G02CA02, nylidrin, The risk or severity of hypertension can be increased when Isoflurane is combined with Nylidrin.]
[H01CB02, octreotide, The risk or severity of QTc prolongation can be increased when Octreotide is combined with Isoflurane.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Isoflurane can be increased when combined with Rilonacept.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Isoflurane is combined with Opium.]
[R03CB03, metaproterenol, The risk or severity of hypertension can be increased when Isoflurane is combined with Orciprenaline.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isoflurane.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxazepam.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Oxolinic acid.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxycodone.]
[C01DX03, oxyfedrine, The risk or severity of hypertension can be increased when Isoflurane is combined with Oxyfedrine.]
[S01GA04, oxymetazoline, The risk or severity of hypertension can be increased when Isoflurane is combined with Oxymetazoline.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, The risk or severity of hypertension can be increased when Isoflurane is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Isoflurane.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[M03AC01, pancuronium, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Papaverine.]
[N05CC05, paraldehyde, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pargyline.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Isoflurane.]
[G04BD11, fesoterodine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Penfluridol.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pentazocine.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Isoflurane.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pergolide.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Perhexiline.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Perphenazine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Phenelzine.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Pheniramine.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Isoflurane.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Isoflurane.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, Isoflurane may decrease the antihypertensive activities of Phenoxybenzamine.]
[A08AA01, phentermine, The risk or severity of hypertension can be increased when Phentermine is combined with Isoflurane.]
[V03AB36, phentolamine, Isoflurane may decrease the antihypertensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The risk or severity of hypertension can be increased when Isoflurane is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Phenylephrine is combined with Isoflurane.]
[R01BA01, phenylpropanolamine, The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Isoflurane.]
[N03AB02, phenytoin, The metabolism of Isoflurane can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Isoflurane can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Physostigmine.]
[C08CX01, mibefradil, Isoflurane may decrease the antihypertensive activities of Mibefradil.]
[N05AG02, pimozide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Pimozide.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pindolol.]
[J05AE01, saquinavir, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Saquinavir.]
[N05AC04, pipothiazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pipotiazine.]
[C09CA02, eprosartan, Isoflurane may decrease the antihypertensive activities of Eprosartan.]
[A02BX03, pirenzepine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Isoflurane is combined with Piritramide.]
[S01BC06, piroxicam, The risk or severity of hypertension can be increased when Piroxicam is combined with Isoflurane.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Grepafloxacin.]
[N02CX01, pizotyline, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[C09CA04, irbesartan, Isoflurane may decrease the antihypertensive activities of Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Isoflurane is combined with Proxibarbal.]
[A10BG02, rosiglitazone, The metabolism of Isoflurane can be decreased when combined with Rosiglitazone.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Isoflurane.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Isoflurane is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Isoflurane can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Isoflurane may decrease the antihypertensive activities of Polythiazide.]
[J05AE03, ritonavir, The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Isoflurane.]
[C07AB01, practolol, Isoflurane may decrease the antihypertensive activities of Practolol.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Prajmaline.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Isoflurane is combined with Prazepam.]
[C02CA01, prazosin, Isoflurane may decrease the antihypertensive activities of Prazosin.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Prenylamine.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Prilocaine is combined with Isoflurane.]
[P01BA03, primaquine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Primaquine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Isoflurane.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Probucol.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Procainamide.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Procarbazine.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Isoflurane.]
[N04AA04, procyclidine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[N05AA03, promazine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Promazine.]
[R06AD02, promethazine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Promethazine.]
[C01BC03, propafenone, The risk or severity of hypertension can be increased when Isoflurane is combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Isoflurane is combined with Propanidid.]
[A03AB05, propantheline, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Periciazine.]
[N05CM06, propiomazine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Romidepsin.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Isoflurane is combined with Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Isoflurane is combined with Dextropropoxyphene.]
[C07AA05, propranolol, Isoflurane may decrease the antihypertensive activities of Propranolol.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Isoflurane is combined with Rizatriptan.]
[B01AC09, epoprostenol, Isoflurane may decrease the antihypertensive activities of Epoprostenol.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Protriptyline is combined with Isoflurane.]
[R01BA02, pseudoephedrine, The risk or severity of hypertension can be increased when Isoflurane is combined with Pseudoephedrine.]
[N05AX12, aripiprazole, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Isoflurane is combined with Dalfampridine.]
[A03AB15, diphemanil, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Isoflurane.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Isoflurane is combined with Pyrantel.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Pyridostigmine.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Isoflurane is combined with Mepyramine.]
[C01BA01, quinidine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[P01BC01, quinine, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Quinine.]
[C02AA01, rescinnamine, Isoflurane may decrease the antihypertensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Isoflurane.]
[R03AC05, rimiterol, The risk or severity of hypertension can be increased when Isoflurane is combined with Rimiterol.]
[G02CA01, ritodrine, The risk or severity of hypertension can be increased when Isoflurane is combined with Ritodrine.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxitriptan.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Roxithromycin.]
[A16AA02, S-adenosylmethionine, The metabolism of Isoflurane can be decreased when combined with Ademetionine.]
[N02BA05, salicylamide, The risk or severity of hypertension can be increased when Isoflurane is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hypertension can be increased when Isoflurane is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of hypertension can be increased when Isoflurane is combined with Salicylic acid.]
[S01FA02, scopolamine, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Isoflurane.]
[V04CK01, secretin, The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Isoflurane.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Isoflurane is combined with Selegiline.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Isoflurane is combined with Obinutuzumab.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Isoflurane.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Sotalol.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Isoflurane.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Isoflurane is combined with Isosorbide mononitrate.]
[H02CA04, levoketoconazole, The metabolism of Isoflurane can be decreased when combined with Levoketoconazole.]
[M01AE11, tiaprofenic acid, The risk or severity of hypertension can be increased when Isoflurane is combined with Tiaprofenic acid.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Isoflurane is combined with Etacrynic acid.]
[R03BB01, ipratropium bromide, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
